The risk of recurrence in breast cancer patients treated with tamoxifen: polymorphisms of CYP2D6 and ABCB1.
about
The effect of ABCB1 polymorphisms on the outcome of breast cancer treatmentPharmacogenomics of breast cancer therapy: an updatePersonalizing health care: feasibility and future implications.CYP2D6 genotype and tamoxifen response for breast cancer: a systematic review and meta-analysis.Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversyActionable pharmacogenetic markers for prediction and prognosis in breast cancer.CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patientsFunctional polymorphisms in xenobiotic metabolizing enzymes and their impact on the therapy of breast cancer.ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen.Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment.Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studies.CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: a meta-analysis.Pharmacogenomics toward personalized tamoxifen therapy for breast cancer.Impact of CYP2D6 polymorphisms on endoxifen concentrations and breast cancer outcomes.Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1.A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen.Analysis of CYP2D6 genotype and response to tetrabenazine.Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer.The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis.Precision medicine: does ethnicity information complement genotype-based prescribing decisions?The Underrated Risks of Tamoxifen Drug Interactions.A Simulation Study to Compare the Treatment Effect of Tamoxifen by CYP2D6 Genotypes and Third-Generation Aromatase Inhibitors.
P2860
Q26749954-ABF0024F-8065-4666-99A5-99BBFEE723D2Q27006783-1DD823C6-87C1-48BA-839C-D80E6BDCD0ECQ34938911-9053781C-C232-4A61-97BE-0A3653C152C0Q35009604-044260AE-5B96-45C7-A7C0-2CF20F3AF16CQ35056229-F794BA66-CF00-410B-9858-476376902D7DQ35879741-0E1A332A-22D0-4936-BBC4-8D7460866125Q36441557-C021EE97-9BAC-4360-AA5C-BCAE13A4EB27Q36550926-06597915-3F17-4BC2-81FF-EEEDA52CB906Q36808170-9A9D2DF0-88CF-41EF-BCF5-0D7B6552A74AQ37170578-69F4B754-AAD7-49A4-9856-3363573A40C3Q38105253-44AA439E-9B08-4B8F-9895-13B5CFE59E87Q38109822-61B59205-3A65-439A-9DDF-154950A84C74Q38364888-F31B390C-1887-4958-913A-6326D67BF8ADQ38649909-C68F0B1A-BCA0-482F-A95C-EFE1F8F75357Q39042324-F033BF2B-5DB7-4C72-8C89-1A586834DC25Q39752018-BFFBE2B5-EED1-4A20-A118-A53E2BA6EB5CQ40639052-1D87F742-53CF-477D-A147-885D2AA45CC5Q43478633-65F69123-B172-4092-AC59-5CBCB7800768Q43987491-6C20ADA4-3F5F-44D5-B95D-B2E25E83A21EQ45987663-1B42A4F2-C161-4508-AAB7-51D127EA31F2Q47566249-6259058B-F05C-4BA6-A563-D3F0C4E3AF4FQ52325476-964A85BF-8909-4C45-95EF-89B9BBD7F567Q53116333-EF4424D5-860D-4567-A767-C04A3634262D
P2860
The risk of recurrence in breast cancer patients treated with tamoxifen: polymorphisms of CYP2D6 and ABCB1.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The risk of recurrence in brea ...... morphisms of CYP2D6 and ABCB1.
@ast
The risk of recurrence in brea ...... morphisms of CYP2D6 and ABCB1.
@en
type
label
The risk of recurrence in brea ...... morphisms of CYP2D6 and ABCB1.
@ast
The risk of recurrence in brea ...... morphisms of CYP2D6 and ABCB1.
@en
prefLabel
The risk of recurrence in brea ...... morphisms of CYP2D6 and ABCB1.
@ast
The risk of recurrence in brea ...... morphisms of CYP2D6 and ABCB1.
@en
P2093
P2860
P1433
P1476
The risk of recurrence in brea ...... morphisms of CYP2D6 and ABCB1.
@en
P2093
J J Saladina
J K S Shia
M Rohaizak
M Z Salleh
P2860
P2888
P356
10.1208/S12248-011-9313-6
P407
P577
2011-12-20T00:00:00Z
P5875
P6179
1050484745